INOVIQ Limited Investor Update June 2024

INOVIQ Limited presented an investor update in June 2024 outlining its next-generation diagnostics and therapeutics platform, including its exosome platform technology and SubB2M cancer diagnostics applications. The presentation details the company's strategic catalysts and provides a transaction summary for a proposed placement of new shares to sophisticated investors.